Kinnate Biopharma Inc (DELISTED) (KNTE:DL)
2.65
0.00 (0.00%)
USD |
NASDAQ |
Apr 03, 16:00
Kinnate Biopharma Cash from Financing (Quarterly): 0.00 for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.057M |
| June 30, 2023 | 1.251M |
| March 31, 2023 | -9.116M |
| December 31, 2022 | 0.193M |
| September 30, 2022 | 0.19M |
| June 30, 2022 | 0.652M |
| March 31, 2022 | 0.125M |
| Date | Value |
|---|---|
| December 31, 2021 | 0.557M |
| September 30, 2021 | 0.193M |
| June 30, 2021 | 35.49M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 253.73M |
| September 30, 2020 | 97.16M |
| June 30, 2020 | 0.018M |
| March 31, 2020 | -0.013M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-9.116M
Minimum
Mar 2023
253.73M
Maximum
Dec 2020
23.78M
Average
0.1915M
Median
Cash from Financing (Quarterly) Benchmarks
| XOMA Corp | -4.956M |
| Societal CDMO Inc (DELISTED) | -0.854M |
| NGM Biopharmaceuticals Inc (DELISTED) | 0.111M |
| Avrobio Inc | 0.03M |
| Landos Biopharma Inc | 0.00 |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -17.36M |
| Cash from Investing (Quarterly) | 22.70M |
| Free Cash Flow | -100.04M |
| Free Cash Flow Per Share (Quarterly) | -0.3685 |
| Free Cash Flow Yield | -81.06% |